Comparative risk of incident malignancies in rheumatoid arthritis patients treated with Janus kinase inhibitors or bDMARDs: observational data from the German RABBIT register
Martin Schäfer, Alina Purschke, Vera Zietemann, T. Rudi, Yvette Meißner, Adrian Richter, Sylvia Berger, Karin Rockwitz, Klaus Krüger, Karl Matthias Schneider, Anne C. Regierer, Anja Strangfeld
Topics & Concepts
MedicineRheumatoid arthritisObservational studyTofacitinibJanus kinaseGermanRegister (sociolinguistics)DermatologyInternal medicineOncologyArchaeologyPhilosophyCytokineLinguisticsHistoryRheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and TreatmentsPsoriasis: Treatment and Pathogenesis